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Abstract.  The central nervous system produces 
growth factors that stimulate proliferation of ameboid 
microglia during embryogenesis and after traumatic  in- 
jury. Two microglial mitogens (MMs)are recovered 
from the brain of newborn rat.  MM~ has an approxi- 
mate molecular mass of 50 kD and a pI of ~6.8; 
MM2 has a molecular mass of 22 kD and a pI of 
,',,5.2.  These trypsin-sensitive proteins show specificity 
of action upon glia in vitro serving as growth factors 
for ameboid microglia but not astroglia or oligoden- 
droglia.  Although the MMs did not stimulate prolifer- 
ation of blood monocytes or resident peritoneal mac- 
rophage,  MM~ shows granulocyte macrophage 
colony-stimulating activity when tested upon bone 
marrow progenitor cells. 
Microglial mitogens may help to control brain 
mononuclear phagocytes in vivo. The MMs first ap- 
pear in the cerebral cortex of rat during early develop- 
ment with peak levels around embryonic day E-20, a 
period of microglial proliferation.  Microglial mitogens 
are also produced by traumatized brain of adult rats 
within 2 d after injury. When infused into the cerebral 
cortex, MM~ and MM2 elicit large numbers of 
mononuclear phagocytes at the site of injection.  In 
vitro study shows that astroglia from newborn brain 
secrete MM2. These observations point to the exis- 
tence of a regulatory system whereby secretion of pro- 
teins from brain glia helps to control neighboring 
inflammatory responses. 
LIA of the brain  proliferate or differentiate  during 
distinct periods of development within discrete areas 
of the central nervous  system (CNS).~ One mecha- 
nism to control local glial environments  involves the secre- 
tion  of glia-specific  growth  factors  (Giulian  and  Young, 
1986). Many laboratories have shown the presence of mito- 
gens in the brain that act selectively upon astroglia (Pruss et 
al., 1981; Leutz and Schachner,  1981; Giulian et al., 1988b) 
or oligodendroglia  (Giulian  et al.  1986a;  McMorris and 
Dubois-Dalcq, 1988). We now report a third family of brain- 
derived growth factors which are mitogens for microglia. 
Ameboid  microglia  are  a  class  of brain  mononuclear 
phagocytes (Rio-Hortega, 1932) which act as immunoeffec- 
tor cells in the CNS through  such mechanisms as antigen 
presentation, cytokine secretion, cell killing,  and phagocy- 
tosis (Giulian and Baker, 1986; Giulian et al., 1986b; Frei et 
al.,  1986; Giulian,  1987). During the acute phase of brain 
injury, ameboid microglia migrate to the wound site, prolif- 
erate, and engulf debris (Rio-Hortega,  1932).  Although  it 
has  long been suspected that  injured brain contains  sub- 
stances that mediate inflammatory  responses (Rio-Hortega, 
1932; Oehmichen,  1983; Graeber et al.,  1988), the events 
controlling  proliferation  of ameboid microglia  remain un- 
1. Abbreviations  used in this paper: ac-LDL, acetylated  low density lipo- 
protein; CNS,  central nervous system;  CSF,  colony-stimulating  factors; 
DiI, 1, l'-dioctadecyl-l-3,3,3',3'-tetramethyl-indo-carbocyanineperchotate; 
GM, granulocyte-macrophage;  MM, microglial mitogen. 
known. In this report, we describe two proteins,  referred to 
as microglial  mitogens (MMs), that promote the growth of 
ameboid microglia in vitro and in vivo. These trypsin-sensi- 
tive factors appear at sites of brain injury or within develop- 
ing cerebral cortex at times of microglial  proliferation  with 
one of them produced by astroglia.  When infused into the 
brain at physiologic  concentrations,  the MMs stimulate the 
appearance of mononuclear phagocytes.  We propose that 
MMs serve as immunoregulators  in the CNS by action upon 
phagocytic  cell populations. 
Materials and Methods 
Cell Cultures 
Mixed glial cell cultures were prepared as described earlier (Giulian et al., 
1980a) from dissociated cerebral cortex of newborn albino rats (Holtzman, 
Madison, WI). Cells were placed in 35-ram plastic dishes upon poly-L- 
lysine-coated  glass coverslips  in chemically defined culture medium (Bot- 
tenstein and Sato,  1979) supplemented with 10% fetal bovine serum; after 
48 h, cells were grown in chemically defined medium without serum. Ame- 
boid microglia were isolated from the brains of newborn rat using the 
method of Giulian and Baker (1986). 
Astroglia isolated by the method of McCarthy and De Vellis (1980) were 
plated at 5 x  106 on 100-mm plastic dishes and freed of microglla by incu- 
bation with 10 mM L-leucine methyl ester (Sigma Chemical Co., St. Louis, 
MO) (Giulian and Baker,  1986) plus 500 pg/dish of carbonyl iron (Sigma 
Chemical Co.) OVong  and Varesio, 1984). 24 h later, iron particle-engulfing 
microglia were removed  by a  magnet. Enriched glial preparations were 
grown on glass coverslips (without poly-L-lysine coating) for 24 h in chemi- 
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showing the effects of brain extracts  upon 
growth  of ameboid microglia.  Brain ex- 
tracts were obtained from animals of differ- 
ent ages and incubated with mixed cell cul- 
tures for 72 h at a concentration of 200 ~g 
protein per ml of chemically defined me- 
dium. Ameboid microglia were  identified 
as DiI-ac-LDL(+) cells.  (A) Control cul- 
ture;  (B)  extract  from  embryonic stage 
E-18; (C) extract from adult rat. As shown, 
the developing  rat brain contained factors 
that stimulated  the appearance of DiI-ac- 
LDL(+) microglia. These stimulated  cul- 
tures often contained  dense clusters of ame- 
boid cells (B). Bar, 20 ~tm. 
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Figure 2. Azneboid micmglial proliferative activity found in brains 
of different ages. (A) 200 t~g of brain extract were added for 72 h 
to glial cultures grown in chemically defined medium.  Data,  ex- 
pressed as mean number of DiI-ac-LDL(+) ameboid microglia per 
microscopic field 5: SEM, were obtained from at least five cultures 
per group. As shown, the greatest microglial growth activity was 
found in cerebral cortex obtained from embryonic stage E-16 to 
the time of birth (PN-1). (8) Dose response curves for mitogenic 
activity recovered from extracts of developing and mature brains. 
Data,  expressed as mean  fold increase in microglial number  + 
SEM when compared to control cultures,  were obtained from at 
least  five cultures  per time point.  Greater biologic activity per 
microgram brain protein was noted in cerebral cortex of animals 
from the perinatal period.  (o) E20;  (e) PN1;  (zx) adult. 
cally defined culture medium plus 10% fetal bovine serum and then trans- 
ferred to chemically  defined medium alone. 
Resident peritoneal  macrophnges were isolated from adult albino rats 
(Holtzman, Madison WI) by the method of Daems (1980) and blood mono- 
cytes by ficoll/sodium  diatrizoate  gradients  (Boyum,  1968) followed by 
adhesion to plastic. Mononuclear  cells from adult rat bone marrow were 
isolated as described by Metcalf (1984) with mononuelear phagocytes re- 
covered by adhesion to glass coverslips. Monoeytes, adherent marrow cells, 
and  macrophages  were  grown  under  conditions  identical  to  those  of 
microglia and astroglia. 
Identification of  Glial Cells 
Ameboid  microglia  were  identified  by  fluorescence  microscopy  using 
acetylated low density lipoprotein (ac-LDL) bound to the fluorescent probe 
1,1'-dioctadecyl-l-3,3,3',3"tetramethyl-indo-earbocyanine perchlorate  (DiI; 
Pitas et al., 1981; Giulian and Baker, 1986). In vitro labeling was carried 
out in chemically defined medium with 1 ~g/ml of DiI-ac-LDL for 12 h at 
37°C. The DiI-ac-LDL was obtained from Biomedical Technologies, Inc. 
(Cambridge, MA). Cultured ameboid cells were also visualized by monitor- 
ing phagocytosis  of fluorescently  labeled  polystyrene  microspheres  (0.7 
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Figure 3. Presence of microglial mitogens in extracts from cerebral 
cortex.  Soluble  protein  recovered  from  injured  adult  3  d  after 
trauma,  normal adult,  and  newborn rat were fractionated by gel 
filtration (BioGel P-10, 95  x  0.8 cm) in 150 mM PBS. Data are ex- 
pressed as mean fold increase in microglial number +  SEM when 
compared to control cultures. Three peaks of microglial prolifera- 
tive activity were observed in some tissues.  The two microgenic 
factors with larger molecular masses, designated MM~ and MM2, 
were found only in injured adult and newborn brain. The third peak 
of biologic activity with a low molecular mass was common to all 
brain extracts and not further studied. 2 mg of soluble brain protein 
were applied to each column.  Each fraction contained 670/~1 of 
which 25/~1 were used in triplicate cultures to test biologic activity. 
microns;  Covaspheres Particles,  FX Green,  Duke Scientific Corp., Palo 
Alto, CA) and by histochemistry  for non-specific esterase  (Koski et al., 
1976).  Standard  indirect  immunofluoreseence  techniques  were  used  to 
identify  astroglia  containing  glial  fibrillary  acidic  protein  (GFAP) and 
oligodendroglia  containing  galactocerebroside  (C-C) (Giulian  et  al., 
1986a). 
Bioassays 
To test for mitogenic effects, cells grown in 1.5 ml chemically defined cul- 
ture medium were incubated with increasing concentrations of growth fac- 
tors  for 72  h.  Proliferation  of ameboid  microglia,  astroglia,  oligoden- 
droglia,  peritoneal  macrophage,  blood  monocytes,  and  adherent  bone 
marrow cells were monitored by scoring the number of specifically labeled 
cells in nine randomly  selected fields (0.314 mm  2) from each of three or 
more coverslips. The data were expressed as fold increase over control cul- 
tures incubated with matching aliquots of PBS ranging from 1 to 50 t~l/ml. 
1 U of MM activity represents the amount of factor needed to double the 
number ameboid microglia in newborn rat brain cultures after a 72-h incu- 
bation in 1.0 ml of chemically defined medium. Specific activities were ex- 
pressed as units per t~g protein as determined by the fluoreseamine assay 
(Bohlen et al.,  1973). 
To measure  [3I-I]thymidine incorporation,  isolated  ameboid  microglia 
were placed in 96-well plates (50,000 cells per well) and incubated for 72 h 
in 200 t~l of chemically defined medium containing various concentrations 
of MMs. During the last 15 h of the incubation period, 0.5/~Ci of [3H]thy- 
midine (26 Ci/mmol; Amersham Corp., Arlington Heights, IL) were added 
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Figure 4. Molecular masses for microglial mitogens as estimated 
by HPLC  gel  filtration.  Protein was  separated by two  TSK  125 
columns in series (300  x  7.5 mm) with an elution buffer of 200 
mM PBS at a flow rate of 0.5 ml/min. MM~ was found to have an 
apparent mass of 50 kD and MM2 to have a mass of'0 20 kD. Data 
are expressed as mean fold increase in microglial number +  SEM 
when compared to control cultures. Each fraction contained 500 
#l of which 25/d  were used in triplicate cultures to test biolog- 
ic activity.  Molecular mass markers (zx) are  shown in the upper 
panel. 
to each well. Cells were frozen at -80°C, iysed in deionized water, and har- 
vested onto glass filters (Skatron harvester; Skatron,  Inc., Sterling,  VA). 
Radioactivity bound to the glass filters was measured by liquid scintillation 
counting using Scintiverse E (Fisher Scientific Co., Pittsburgh, PA). 
Colony-stimulating activity was monitored by the agar culture system de- 
veloped by Metcalf (1984). Marrow cells from adult rat femur (2 x  lO  s af- 
ter erythrocyte lysis with 3 % acetic acid) were placed in 35-mm plastic cul- 
ture dishes containing 2.0  ml of 0.3%  agar  (Sigma  Chemical Co.)  in 
Duibecco's minimal essential medium with 20% fetal bovine serum, 6/~g/ml 
L-asparagine (Sigma Chemical Co.), and 22.5 #g/mi dextran (Sigma Chem- 
ical Co.). After 7 d in culture,  500 ng of DiI-ac-LDL were added and cul- 
tures fixed with 10% formaldehyde  12 h later. The total number of colonies 
(defined as >50 cells per cluster; see Metcalf,  1984) were determined using 
a dissecting microscope (40x  Nikon). Agar cultures were then dried on 
filter paper and the total number of DiI-ac-LDL(+) colonies per dish were 
determined using fluorescence  microscopy  (100x).  The classification  of 
colony types in the dried agar preparations was made using the criteria of 
Metcalf (1984) aiter staining with 0.2%  luxol fast blue and hematoxylin. 
Isolation of  Microglial Mitogens 
Cerebral cortices from albino rats of different ages were isolated,  stripped 
of meninges, and dispersed by mild sonication in 150 mM PBS (1:10 [wt/ 
vol]).  The brain sonicate was centrifuged  at 15000 g for 15 rain and the 
supernatant passed through a 0.4-#m filter. MMs were isolated by gel filtra- 
tion using a P10 column (95 x  0.8 cm; Bio-Rad Laboratories, Richmond, 
CA) with 150 mM PBS (pH 7.4) as the eluting buffer (Giulian et al., 1985) 
and concentrated by ultraliltration through YM 10 filters (Amicon Corp., 
Danvers, MA). Molecular masses of the MMs were estimated by gel filtra- 
tion HPLC using two TSK-125 columns (300 x 7.5 ram; Waters Associates, 
Milford, MA) in series that had been standardized with proteins of known 
molecular masses (range 5-90 kD). 
Two methods for IEF were used. An analytic method used slab gels of 
acrylamide (5 x  10 × 0.1 cm; LKB Instruments, Inc., Gaithersbnrg, MD) 
with 3,000 V, constant current for 1.5 h on an ice-chilled cooling plate. The 
pH gradient was measured directly from the IEF gel with an Ingold pH sur- 
face electrode (Fisher Scientific Co.) MMs were eluted from 0.5  x  4 cm 
slices of gel into sterile deionized water by vigorous shaking for 12 h at 4°C. 
The eluate was concentrated with a SpeedVac Concentrator (Savant, Farm- 
ingdale,  NY), filtered through 0.2-/~m filter, and assayed for mitogenic ac- 
tivity.  Alternatively,  preparative IEF  was  processed  using the  Rotofor 
Preparative Iso~lectric Focusing  Cell (Bio-Rad  Laboratories). Fractions 
recovered  from gel filtration chromatography were pooled and dialyzed 
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Figure 5. Separation of MMs by isoelectric focusing (pH gradient, 
e). Partially purified growth factors were fractionated by IEF using 
a  horizontal slab gel method.  Gel strips were eluted overnight in 
sterile water and assayed for the presence of microglial proliferative 
activity  (o).  Data  are  expressed  as  mean  fold  increase  in 
microglial number +  SEM when compared to untreated cultures. 
The apparent isoelectric point for MM]  was  ,06.8  and ,05.2  for 
MM2  were  similar to those  found using the  Rotofor  Isoelectric 
Cell.  Eluted samples from an IEF control gel (zx, bottom) showed 
that small amounts of recovered ampholytes did not affect numbers 
of microglia in culture. 
against  deionized water overnight.  After dialysis,  2.5 ml of Servalyt pH 
3-10 iso-dalt  grade arnpholyte  solution (40%  arnpholyte  [wt/vol];  Serva 
Fine Biochemicals  Inc., Garden City Park, NY) was added to the sample, 
and the volume brought up to 50 ml with deiouized H20 to give a final 2 % 
ampholyte concentration. The sample was separated by isoelectric focusing 
for 4-5 h at 12 W constant power at 4°C into 20 fractions.  After determin- 
ing pH, each fraction was sterilized by filtration and tested for biologic ac- 
tivity. (Control experiments showed no effect of eluted ampholytes upon cul- 
tured microglia.) This material was also fractionated by reverse phase high 
performance liquid chromatography (RP-HPLC;  75  x  4.6-ram Ultrapore 
C8 column; Beckman Instruments, Inc., Pals Alto, CA) using an acetoni- 
trile gradient (0-55% over 52 rain at 1 ml per rain) with deionized water 
containing 0.08 % trifluoroacetic  acid. 
SDS-PAGE used the method of Neville (1971) with a 20% polyacryl- 
amide separating gel and a 4% stacking gel (13  x  7  x  0.15 cm). MM2 
samples were mixed with buffer (30% glycerol,  2.8 M 2-mercaptoethanol, 
0.25% SDS, and 1% brompbenol blue, in Tris-HCl buffer, pH 8.4), placed 
in boiling water for 5 rain, and centrifuged for 2 rain at 15,000 g.. The sam- 
ples were then separated by electrophoresis at room temperature using 21 
mA constant current for 3.25 h. The gels were fixed and stained with silver 
as described by Poehiing and Nenhoff (1981). Unstained slices of gel (2.0 
x  7.5 cm) were eluted in deiouized water and processed as described above 
for IEF gels. Low molecular weight toxins found in the concentrated eluate 
were  removed  by gel filtration chromatography (BioGel  P2; 21.0 cm  × 
0.8 cm column) before assay. 
To measure protease-sensitivity,  MMs were incubated with trypsin (type 
IX; Sigma Chemical Co.,  1 pg trypsin for 100 ~g protein) for 60 rain at 
37°C.  Enzymic activity was inhibited with soy bean trypsin-chymotrypsin 
inhibitor (T 9777; Sigma Chemical Co.; 2 ~g inhibitor for 1 ~g trypsin). 
Surgical Procedures 
A penetrating injury to adult rat brain was inflicted with a flame-heated 25 
gauge needle mounted on a  stereotaxic  device (David Kopf Instruments, 
Tujanga, CA) and inserted through a burr hole to a depth of 1.0 mm in the 
cerebral cortex (Giulian et al., 1988a). At different intervals after surgery, 
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were  incubated in  200  /~1  of culture medium  for 24  h.  Production of 
microgliai mitogenic activity was then measured by the standard microglial  3.0 
cell assay. 
To study the effects  of  MMs in vivo, we injected small volumes of  isolated 
growth factors into rat cerebral cortex. Adult rats (250-300 g) were deeply  .o~  2.0 
anesthetized by intraperitoneal injection (a mixture of 8.5 mg/ml xylazine,  E 
42 mg/ml ketamine hydrochloride, and 1.4 mg/ml acepromazine maieate) 
and placed in a stereotaxic device (David Kopf  Instruments). After the scalp  ~  1.0 
was reflected, burr holes were positioned over the cerebral cortex at 4.5 nun  e~ 
caudal to bregrna and 4.0 nun lateral to the sagittal suture. Using a 5.0-#1  o 
syringe (Hamilton Company, Reno, NE) mounted in the stereotaxic device,  "E 
we infused 0.5/~1 of PBS containing a MM at a depth of 1.5 mm from the 
surface of the brain over a 2-min interval. Control injections of PBS or PBS  ~  3.0 
containing 200 ng of cytochrome C were made in an identical location on 
the contraiateral side.  All solutions contained fluorescent microspheres 
(1:1500 [wt/voi]: Covaspheres Particles, FX Green, Duke Scientific Corp.)  "-  2.0 
in order to mark the site of infusion. The syringe needle was slowly with-  -o  o 
drawn and the scalp closed with wound clips. 48 h later, the animals were  u. 
deeply anesthetized and cylindrical biopsies (2.0 ×  1.0 nun) were removed  1.0 
rapidly  from  the  injection  sites  after  cardiac  perfusion  with  heparin- 
phosphate buffeted saline solution (500 USP U/liter). The tissue samples 
were then incubated for 12 h at 37"C in 0.5 ml of chemicaily defined culture 
medium containing 2 ~g/ml DiI-ac-LDL. The tissues were fixed with 3 % 
formaldehyde  in PBS for I h and viewed at 200 × using fluorescence micros- 
copy and photographed immediately. Comparisons were made between the 
mean number of DiI-ac-LDL(+)  cells found per field in MM-injected, 
PBS-injected, and cytochrome C-injected sites as delineated by the pres- 
ence of coinjected microspheres. 
Results 
Many investigators have noted microglial proliferation dur- 
ing  early  brain  development  (Rio-Hortega,  1932;  Ling, 
1981;  Matsumoto  and  Ikata,  1985;  Giulian  and  Baker, 
1986). The rapid increase in numbers of microglia found in 
embryonic  cerebral  cortex  (Ling,  1981;  Matsumoto  and 
Ikuta,  1985; Giulian et al.,  1988b) suggest the presence of 
mitogenic  factors driving  cell proliferation.  Extracts  ob- 
tained from the cerebral cortices of rats of different ages 
were added to mixed glial cultures for 72 h.  There was a 
significant increase in the number of DiI-ac-LDL(+) ame- 
boid microglia in cultures grown in the presence of em- 
bryonic brain extracts (Fig.  1). The developmental pattern 
showed that rat cerebral cortex contained microglial growth 
factors between embryonic day E-16 and PN-1  (Fig. 2 A). 
Dose response curves (Fig. 2 B) demonstrated the greatest 
brain concentrations of microglial mitogenic activity near 
the time of  birth. Study of  tissue biopsies indicated that 1 mg 
of cerebral cortex of newborn rat released 1.3  +  0.3 U of 
microglial mitogenic activity within a 24-h period; in con- 
trast  no  significant biologic  activity was  associated  with 
crude extracts from normal adult brain.  When compared 
with other glia-promoting factors,  the peak of microglial 
mitogenic activity was similar to that of astroglial growth 
factors in developing rat cerebral cortex but before the post- 
natal burst seen for oligodendroglia growth factors (Giulian 
et al.,  1986a; Giulian and Young,  1986). 
Microglial Mitogens Found in Developing Brain 
Extracts  from  newborn  brain  separated  by  gel  filtration 
showed three peaks of mitogenic activity (Fig.  3). Two of 
these peaks, designated MM, and MM2,  were not detected 
in normal adult brain.  The third peak of biologic activity, 
common to all extracts from cerebral cortex, was not studied 
further. Gel filtration HPLC indicated MM~ has an appar- 
ent molecular mass of "~50 kD (Fig. 4) while slab gel IEF 
showed an approximate isoelectric point of 6.8  +  0.2 (n  = 
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Figure 6. Isolation of microglial mitogens by RP-HPLC. Using a 
C8 column and a gradient of acetonitrile in water containing 0.1% 
trifluoroacetic  acid,  it  was  possible  to  elute  MM~  at  ~48% 
acetonitrile and MM2 at *30% acetonitrile. Data are expressed as 
mean fold increase in microglial number +  SEM when compared 
to control cultures. Each fraction contained 150 drops; 25/~1 were 
tested in triplicate for biologic activity. 
4; see Fig. 5). MM2 was found to have an apparent molecu- 
lar mass of 20 kD (Fig. 4) and an isoelectric point of 5.2 + 
0.2 (n  =  6; Fig. 5). These factors could also be separated 
by RP-HPLC with a single peak of MM1 eluting at 45--48 % 
acetonitrile  and  a  peak  of MM2  at  27-30%  acetonitrile 
(Fig. 6). A purification scheme combining gel filtration, IEF, 
and RP-HPLC yielded between 10,000- and 20,000-fold in- 
creases  in  specific biologic activities for MMI  and MM2 
when  compared to  extracts  of newborn brain  (Table  1). 
These partially purified MMs showed a direct action upon 
microglia both in cell proliferation and in [3H]thymidine in- 
corporation bioassays (Fig. 7) using highly enriched cultures 
of ameboid cells (>98% homogeneous population). 
Table L Isolation of  Microglial Mitogens 
from Newborn Rat Brain 
Specific activity 
Preparation  MM~  MM2 
units per/~g protein 
Extract  -  0.002  - 
Gel filtration  0.06  0.04 
IEF  6.2  5.0 
RP-HPLC  40.0  25.0 
Extracts of newborn brain were prepared by sonication  and centrifugation  at 
15,000 g. Gel filtration with BioGel PI0 separated two distinct microglial mito- 
gens, MM~ and MM2. IEF separation  used the Rotofor Isoelectric  Ceil; RP- 
HPLC used a C8 column with an acetonitrile  gradient. Specific activities ob- 
tained from representative  preparations  are expressed as units of activity per 
/zg of protein. 1 U of MM activity represents the amount of factor needed to 
double the number ameboid microglia in newborn rat brain cultures  after a 
72-h incubation in 1.0 ml of chemically defined medium. Using a combination 
of gel filtration, IEF, and RP-HPLC we estimate at least a 20,000-fold purifica- 
tion of MMt and 12,500-fold for MM~ from extracts of newborn rat cerebral 
cortex. 
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Figure 7. MM1 and MM2 stimulated ameboid microglia to incor- 
porate  [3H]thymidine.  Mitogens  were  isolated  from  newborn 
brain extract by a procedure involving gel filtration, IEF, and RP- 
HPLC. Each value, expressed as mean number cpm -I- SEM, was 
obtained  from  at  least  five  cultures  of isolated  ameboid  cells 
(50,000 cells per well; >98 % homogeneous population) incubated 
with growth factors for 72 h. 
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Figure 9. Microglial mitogens are specific in their action upon brain 
glia. Dose response curves show that MMI and MM2 increase the 
number  of DiI-ac-LDL(+)  ameboid  microglia but  not  GC(+) 
oligodendroglia  or GFAP(+)  astroglia  in  culture.  Data are  ex- 
pressed as mean fold increase in microglial number +  SEM when 
compared to control cultures.  Mitogens were isolated from new- 
born brain extract by a procedure involving gel filtration, IEF, and 
RP-HPLC. 
The effects of trypsin upon MMs were monitored by in- 
cubating partially purified factors with trypsin (1 ~g trypsin 
per  100 #g protein).  The enzymic activity was blocked by 
the addition of soy bean trypsin inhibitor (2 #g inhibitor for 
1 #g trypsin) at the end  of a  60-min  incubation  period  at 
37°C.  Enzyme-treated  controls  received  both  trypsin  and 
trypsin inhibitor before incubation. Trypsin-digested factors 
were applied to mixed glial cultures and the number of DiI- 
ac-LDL(+) microglia were determined after 72 h. Data, ex- 
pressed as fold increase in cell number above PBS-treated 
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Figure  8.  Production  of microglial  mitogens by  injured  brain. 
Three biopsies of adult brain were taken from penetrating  wound 
sites at increasing intervals  after injury and incubated  for 24 h in 
chemically defined medium. The conditioned medium assayed for 
microglial mitogenic activity showed the highest levels of activity 
between days 2 and 5 after penetrating brain injury.  Data are ex- 
pressed as mean fold increase in microglial number +  SEM when 
compared to control cultures. Extracts of injured brain tissue frac- 
tionated by gel filtration showed the presence of both MMI  and 
MM2 (see Fig.  3). 
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Figure  10.  MMs  effects  upon  mononuclear phagocytes isolated 
from outside the CNS. At between 1 and 5 U, MMs had no effect 
upon  resident peritoneal  macrophage (top)  or blood monocytes 
(center).  MMi did, however, stimulate proliferation  of bone mar- 
row progenitor cells (bottom).  Data are expressed as mean fold in- 
crease in cell number +  SEM when compared to control cultures. 
(*) MM1; (A) MM2. 
The Journal of Cell Biology, Volume  112, 1991  328 cultures, showed that trypsin-treated MMt  (2.7  +  0.2-fold 
increase for enzyme control vs.  1.4  +  0.1  trypsin-treated; 
t  =  6.05, df =  13, P  <  0.001) and trypsin-treated MM2 (2.8 
+  0.2-fold increase for enzyme control vs.  1.1  +  0.2 tryp- 
sin-treated;  t  =  6.01, df =  14,  P  <  0.001) had significant 
reductions in biologic activity. Thus, the developing brain 
contains  two distinct trypsin-sensitive proteins  which are 
mitogens for ameboid microglia in culture. 
Microglial Mitogens after Brain Injury 
Since  brain  mononuclear  phagocytes  proliferated  in  re- 
sponse to tissue injury (Rio-Hortega, 1932), we examined 
CNS at sites of trauma for the presence of microglial growth 
factors. Biopsies of injured and intact control tissues were 
incubated in chemically-defined culture medium for 15 h at 
37°C.  Traumatized  brain  tissue  released  the  greatest 
amounts of microglial mitogenic activity between 2 and 5 d 
after injury (Fig. 8). 1 nag of adult rat cerebral cortex recov- 
ered at 2 d after a penetrating injury released '~1.2 +  0.2 U 
of MM activity (from four samples each using three pooled 
of 6 mg each) compared with <0.1 U found in normal adult 
animals (from four pooled samples). Gel filtration chroma- 
tography showed that extracts from injured brain contained 
two microglial mitogens not found in uninjured normal adult 
CNS  (Fig.  3).  These two peaks  of biologic activity cor- 
responded to MMl  and MM2 with the same apparent mo- 
lecular masses (Fig.  3) and isoelectric points as found for 
those growth factors recovered from newborn brain (data not 
shown).  We concluded that identical microgliai mitogenic 
factors were found in developing and injured brain. 
Cell Specificity  of  Microglial Mitogens 
The  specificities of biologic activity  for MMt  and  MM2 
were tested against brain glia in culture. MMs were potent 
mitogens  for ameboid  microglia but  had  no  effect upon 
proliferation  of GFAP(+)  astroglia  or  GC(+)  oligoden- 
droglia in vitro (Fig. 9). These results clearly demonstrated 
that a distinct class of growth factors was recovered from the 
CNS. Coupled with earlier work, these observations reveal 
that cell specific mitogens exist for each of  the brain glial cell 
types. Such selective biologic activities further support the 
notion  that  MMs  serve  as  immunoregulators  of  brain 
mononuclear phagocytes. 
Ameboid microglia are a class of mononuclear phagocytes 
which can be distinguished from resident peritoneal macro- 
phage and blood monocytes by morphology, proliferative ca- 
pacity, and response to growth factors (Giulian and Baker, 
1986; Giulian,  1987). In testing for mitogenic effects upon 
Figure H. Brain-derived MMs and colony-stimulating activity. To compare MMs with colony-stimulating factors, MM1 and MM2 were 
tested for effects upon bone marrow cells grown in culture. Fluorescence photomicrographs showing colonies of cells found in control 
(A), or MMi-stimulated (B), or MM2-stimulated (C) cultures. Dose response curve (D) shows that only MMI promoted formation of 
DiI-ac-LDL(+) colonies (defined as >50 cells per cluster).  (0).MM~; (A) MM2. 
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Total number 
colonies 
MM~ activity  scored  Grail  Mac  Gran-Mac  Other 
%  %  %  % 
1U  42  2  57  40  0 
2  U  47  4  40  57  0 
5  U  117  21  27  48  4 
Bioassays for colony-stimulating activity  used the basic techniques of Metcalf 
(1984) applied  to adult rat bone marrow. 2  x  105 cells were placed in 35-mm 
dishes containing 0.3%  agar with  DMEM  supplemented with  20%  FBS. 
MMj was added at the time of plating. After 7 d, cultures were fixed, dried, 
and stained with iuxol fast blue and hematoxylin (Metcalf,  1984).  A colony 
consists of >50 cells per cluster. As shown, MM~ stimulates formation of cell 
clusters containing predominantly granulocytes (by  convention assigned to 
neutrophils)  or  maeropbages,  suggesting granulocyte-macrophage colony- 
stimulating activity. Increasing concentrations of MM~ stimulate more granu- 
locyte colonies, a pattern noted by Metcalf (1984) for GM-CSF. 1 U of MM~ 
activity represents the amount of factor needed to double the number ameboid 
microglia in newborn rat brain cultures after a 72-h incubation in 1.0 ml of 
chemically defined medium. Gran, neutrophilic granulocytes; Mac, macro- 
phage; Gran-Mac, mixed colonies with neutrophils and macrophages; Other, 
mixed colonies with small unstained cells, eosinophils, neutrophils, and/or 
macropbages. 
mononuclear phagocytes from outside the CNS,  we found 
that MMs did not stimulate proliferation of cultured perito- 
neal macrophage (Fig. 10, top) or blood monocytes (Fig. 10, 
center). We did note,  however, that MM,,  but not MM2, 
stimulated  proliferation of mononuclear phagocytes  from 
bone marrow (Fig.  10, bottom). 
As  described in  previous work,  two  classes  of colony- 
stimulating factors induce proliferation of cultured ameboid 
microglia (Giulian and Ingeman,  1988). To investigate the 
relationship of the brain-derived MMs  and hematopoietic 
growth factors, we tested the MMs for colony-stimulating 
activity. As shown in Fig.  11, MM~, but not MM2,  elicited 
a  striking  growth  of colonies containing  DiI-ac-LDL(+) 
mononuclear phagocytes. Examination of cell types in the 
bone marrow cultures stimulated with growth factor showed 
MM1  had granulocyte-macrophage colony-stimulating fac- 
tor activity (Table II). 
Astroglia and Production of  Microgiial Mitogens 
As  noted  earlier,  there  is  a  close  relationship  between 
proliferating ameboid microglia and astroglia in vitro. We 
examined this  relationship by monitoring MM  activity in 
medium conditioned by cultures of highly purified astroglia 
(>99% homogeneous population). As shown in Fig. 12, cul- 
tured astroglia secrete a single factor with a pI of '~5.2 and 
a molecular mass of ~20 kD; this biologic activity corre- 
sponds to MM2.  Astroglia-secreted MM~ was further puri- 
fied using gel chromatography, preparative Rotofor IEE and 
SDS-PAGE. We found a major protein band with a molecu- 
lar mass  of ,~/22 kD that retained biologic activity when 
eluted from SDS-PAGE (Fig.  13). Our observations link the 
growth of microglia with secretory products from astroglia. 
Astroglia did not secrete detectable levels of MM,, suggest- 
ing different cellular sources for MMt  and MM2 in vivo. 
In Vivo  Biologic Effects of  Microgiial Mitogens 
To investigate the biologic effects of microglial growth factors 
in vivo, we injected highly purified MM~ and MM~ (1-2 U 
each) into the cerebral cortex of adult rats. At 48 h after the 
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Figure 12. Astroglial production of microglial mitogen. Highly en- 
riched  preparations  of astroglia  were  incubated  in  chemically 
defined medium. This medium conditioned for 48 h was fraction- 
ated and tested for microglial mitogen activity. (Top) As shown by 
IEF separation, astroglial conditioned medium contained only one 
peak of biologic activity with a pI of ~5.2. (Bottom)  This biologic 
activity was fractionated further by gel filtration using HPLC. The 
apparent  molecular  mass of '~20  kD  identifies this  factor  as 
MM2. No MMl-like activity was noted in astroglial conditioned 
medium. 
Figure 13. MM2 isolated from astroglial conditioned medium. 500 
ml of medium were concentrated by ultrafiltration (YM-2). The 
biologic activity corresponding to MM2 was next fractionated by 
two consecutive runs of preparative IEE MM2 showing a pI of 
',,5.2-5.3  appeared as a major silver-stained band of protein with 
a molecular mass of 22 kD (lane B). Gel slices were eluted over- 
night with deionized water, concentrated by centrifugation under 
vacuum,  and  fractionated  by gel  chromatography  (BioGel P2, 
21.0 x 0.8 cm). Biologic activity (far  right) recovered from eluted 
gel slices corresponded to the 22-kD band. Data axe expressed as 
mean fold increase in microglial number +  SEM when compared 
to control cultures. Lane A, molecular mass markers (,~200 ng 
each) which include ovalbumin (43 kD), carbonic anhydrase (29 
kD), ~-lactoglobulin (18 kD), lysozyme (14 kD), bovine trypsin in- 
hibitor (6 kD), and insulin (3 kD). 
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graphs  showing the  in  vivo effects of 
microglial mitogens. MMs were infused 
into the cerebral cortex of adult rats and 
as shown in B, D, and F, fluorescent mi- 
crospheres  were coinjected  to confirm 
the sites of infusion. After 48 h DiI-ac- 
LDL(+) mononuclear phagocytes were 
identified  at  injection  sites  of 200  ng 
MM~  (total  1.5  U;  A),  200  ng  cyto- 
chrome  C  (C),  or 200ng  MM2  (total 
1.0  units;  E).  As shown,  there  was a 
marked increase in the number of DiI- 
ac-LDL(+)  mononuclear  phagocytes 
at  the  site  of injection  for MMI  and 
MM2 when compared to cytochrome C 
controls. 
injection of 0.5/zl containing MM1,  MM2, or 200 ng cyto- 
chrome C we found that only MMs increase DiI-ac-LDL(+) 
cells at the site (Fig. 14). The amount of MM activity infused 
into the brain was esl~nated to be in the range of MM activ- 
ity released over a 48-h interval by tissue at the site of pene- 
trating injury in adult cerebral cortex.  We concluded  that 
physiologic concentrations of MMs were capable of activat- 
ing brain mononuclear phagocytes in vivo (Fig.  15). 
Discussion 
Soluble  proteins  found  in  the  CNS help  to  regulate  the 
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_~  mononuclear phagocytes ap- 
-~  pearing after 48 h at MM in- 
-  jection sites. 200 ng of MM1 
wm ~  (1.5 U) ([]), MM2 (1.0 U) (It), 
~_ ~  or 200 ng cytochrome C (in 
o~  0.5 #1 of PBS) (t2) were in- 
jected into the cerebral cortex 
u. o  of adult  rats. Data  are  ex-  i 
=  pressed as mean fold increase 
"  in  the  number of  DiI-ac- 
LDL(+)  cells  per  field  + 
SEM when compared to control sites injected with 0.5 #1 PBS. The 
number of DiI-ac-LDL(+)  mononuclear phagocytes were deter- 
mined for at least five biopsies for each data point. 
growth and differentiation of astroglia (Pruss et al.,  1981; 
Leutz and Schachner, 1981; Giulian et al., 1988b;  Richard- 
son et al.,  1988;  Lim et al.,  1989;  Loret et al.,  1989) or 
oligodendroglia (Giulian and Young,  1986;  McMorris and 
Dubois-Dalcq,  1988).  In this report we establish the pres- 
ence  of  another  class  of brain-derived  growth  factors, 
microglial mitogens. In contrast to oligodendroglia growth 
factors, the MMs appeared early in development and at sites 
of injury. Biochemical properties including apparent molec- 
ular  mass,  pI,  elution  profile  by  RP-HPLC  as  well  as 
specificities of biologic actions, clearly separated astroglia- 
promoting factors from the MMs. Recombinant forms of in- 
terleukin 1 (IL-1), one of the astroglial factors, do not stimu- 
late microglial proliferation. 
Ameboid microglia are the principal immunoeffector  cells 
within the brain (Giulian, 1987) involved in such functions 
as secretion of cytokines, antigen presentation (Frei et al., 
1986), and production of cytotoxins (Giulian, 1990). Recent 
observations  indicate that microglia also  mediate wound 
healing in neural tissues (Giulian et al.,  1989).  This report 
describes the existence of brain-derived mitogens that stimu- 
late the proliferation of ameboid microglia. TheRe mitogens, 
designated MMt and MM2, may be distinguished from one 
another by their apparent molecular masses, their isoelectfic 
points,  and their elution profiles using RP-HPLC.  MM~, 
but not MM2,  stimulates growth of bone marrow-derived 
mononuclear phagocytes. 
We propose that MMt and MM2 help to expand ameboid 
microglia populations during specific periods of  brain devel- 
opment or at sites of CNS injury. Several lines of evidence 
support this hypothesis. First, concentrations of MMs are in- 
creased  during  that  period  of brain  development  when 
microglia undergo rapid proliferation. As these cells lose 
their proliferative capacity (Giulian and Baker,  1986),  the 
brain levels of the MMs decline.  Although normal adult 
brain has only low levels of MMs, these mitogens increase 
dramatically by 2 d after penetrating brain injury. It is during 
this time that large numbers of DiI-ac-LDL(+) ceils appear 
at the wound site (Giulian et al., 1989). In vitro experiments 
show that both MM~ and MM2 have specificity of action for 
brain, mononuclear phagocytes. In vivo experiments show 
that MMs infused into the cerebral cortex elicit local inflam- 
matory responses. Further study will be needed to determine 
if the MMs induce proliferation, chemotaxis, or recruitment 
of quiescent brain cells in vivo. The presence of MMs within 
sites of injury and their ability to elicit an inflammatory re- 
sponse in vivo argues that these growth factors are physio- 
logically important regulators of CNS inflammation. 
Are the brain-derived MMs similar to other known growth 
factors? A recent study of growth factors and immunomodu- 
lators show that only certain classes of colony-stimulating 
factors (CSFs)  induce proliferation of ameboid microglia 
(Giulian and Ingeman,  1988).  In particular,  granulocyte- 
macrophage CSF  (GM-CSF)  and. multiple potential-CSF 
(multi-CSF; also referred to as  interleukin 3)  are potent 
microglial mitogens. These colony-stimulating factors were 
originally identified as  growth  factors  for hematopoietic 
ceils (Metcalf, 1985;  Clark and Kamens, 1987).  Although 
the origin of microglia is uncertain, in vitro studies suggest 
that  the  ameboid  cell  may  be  similar  to  progenitor 
mononuclear phagocytes found in bone marrow (Giulian, 
1987; Giulian and Ingeman, 1988). Importantly, we find that 
MM1 has colony-stimulating factor-like activity. Definitive 
work comparing rat CSFs with brain MMs awaits further 
biochemical study.  Two other reports suggest the presence 
of colony-stimulating factor-like activity within the CNS. In 
the mouse, Nicola et al. (1979) find the brain contains GM- 
CSF-like biologic activity while Frei et ai. (1986) described 
multl-CSF-like activity from cultured brain glia. Our obser- 
vations are in agreement with Nicola et al.  (1979)  in that 
MM1 has GM-CSF activity but neither MMI or MM2 show 
multi-CSF-like effects.  The molecular mass of 50 kD we 
have assigned to rat MM1 does not match human GM-CSF 
(18-22 kD) or mouse GM-CSF (23 kD), but, as noted by 
Metcalf (1984), size estimates of this glycosylated  hemopoi- 
eric growth factor have varied greatly perhaps due to species 
differences and tissue-specific glycosylation. Sequence anal- 
ysis will be needed to determine the structural relationships 
of MMs to other growth factors. 
There is growing evidence that immune system secretion 
products regulate cellular events in damaged neural tissue. 
Neurotoxins  released  by  mononuclear  phagocytes  may 
mediate a variety of neuropathic conditions including loss of 
neurons after stroke (Giulian and Robertson, 1990; Giulian, 
1990).  Moreover, the cytokine IL-1 produced by microglia 
stimulates astrogliosis at  sites  of trauma (Giulian et ai., 
1988a).  We believe that microglial mitogens represent yet 
another class of immunoregulators that influence specific 
cell functions within the brain. As described here, astroglia 
stimulate microgliai proliferation by secretion of a mitogen. 
Thus, we have a reciprocal relationship between two classes 
of brain glia. Understanding the mechanisms that control 
microglial populations may lead to new strategies to limit the 
extent and nature of CNS tissue damage. 
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